Joanna Yi MD

PubMed

• Acute Leukemia in the Crosshairs: First-in-Class Menin Inhibitor Approval for Adults and Children.
  Joanna S Yi, Branko Cuglievan
  Pediatric Blood & Cancer. 2025-03-18
• MLL oncoprotein levels influence leukemia lineage identities.
  Derek H Janssens, Melodie Duran, Dominik J Otto, Weifang Wu, Yiling Xu
  Nature Communications. 2024-10-29
• EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion.
  Nathaniel J Buteyn, Connor G Burke, Vincent J Sartori, Eve Deering-Gardner, Zachary J DeBruine
  Biorxiv. 2024-06-25

Abstracts/Posters

• An Oncogenic Enhancer Encodes Selective Selenium Dependency in AML
  Joanna S. Yi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...
  Joanna S. Yi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Rara Is a Druggable Super-Enhancer Regulated Dependency in Pediatric AML
  Joanna S. Yi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Pa... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019